1,211
Participants
Start Date
April 30, 2009
Study Completion Date
June 30, 2011
Levonorgestrel (Mirena, BAY86-5028)
Women using Mirena for treatment of menorrhagia
Hormonal treatment
Hormonal treatment (including combined oral contraceptives or oral or injectable progestogens)
Antifibrinolytic treatment
Antifibrinolytic treatment (such as tranexamic acid)
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Lead Sponsor
Bayer
INDUSTRY